ASRS
CRSP icon

Arizona State Retirement System’s CRISPR Therapeutics CRSP Stock Holding History

Arizona State Retirement System’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.27M Sell
23,271
-288
-1% -$15.2K 0.01% 1031
2026
Q1 		$1.12M Buy
23,559
+882
+4% +$46.5K 0.01% 1028
2025
Q4 		$1.19M Sell
22,677
-1,590
-7% -$95.2K 0.01% 1021
2025
Q3 		$1.57M Buy
24,267
+394
+2% +$22.6K 0.01% 913
2025
Q2 		$1.16M Buy
23,873
+656
+3% +$25.4K 0.01% 1026
2025
Q1 		$790K Sell
23,217
-251
-1% -$10.6K 0.01% 1181
2024
Q4 		$924K Buy
23,468
+239
+1% +$11.3K 0.01% 1144
2024
Q3 		$1.09M Buy
23,229
+650
+3% +$33K 0.01% 1055
2024
Q2 		$1.22M Buy
22,579
+1,841
+9% +$106K 0.01% 942
2024
Q1 		$1.41M Sell
20,738
-351
-2% -$25.1K 0.01% 874
2023
Q4 		$1.32M Sell
21,089
-262
-1% -$14.5K 0.01% 889
2023
Q3 		$969K Buy
21,351
+365
+2% +$18.9K 0.01% 1011
2023
Q2 		$1.18M Sell
20,986
-565
-3% -$32.1K 0.01% 928
2023
Q1 		$975K Buy
21,551
+640
+3% +$31.1K 0.01% 1023
2022
Q4 		$850K Buy
20,911
+915
+5% +$48.5K 0.01% 1067
2022
Q3 		$1.31M Buy
19,996
+120
+0.6% +$8.7K 0.01% 790
2022
Q2 		$1.21M Buy
19,876
+3,327
+20% +$196K 0.01% 861
2022
Q1 		$1.04M Buy
16,549
+142
+0.9% +$8.92K 0.01% 1049
2021
Q4 		$1.24M Sell
16,407
-104
-0.6% -$9.09K 0.01% 975
2021
Q3 		$1.85M Buy
16,511
+108
+0.7% +$13.6K 0.02% 752
2021
Q2 		$2.65M Sell
16,403
-810
-5% -$98.5K 0.02% 615
2021
Q1 		$2.1M Buy
17,213
+1,951
+13% +$295K 0.02% 708
2020
Q4 		$2.34M Sell
15,262
-214
-1% -$25.3K 0.02% 620
2020
Q3 		$1.29M Buy
15,476
+6,549
+73% +$581K 0.01% 791
2020
Q2 		$656K Buy
8,927
+1,875
+27% +$110K 0.01% 977
2020
Q1 		$299K Buy
+7,052
New +$364K 0.01% 1288

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Arizona State Retirement System's CRSP Position: Q2 2026 in Review

Arizona State Retirement System reduced its CRISPR Therapeutics (CRSP) stake by 1.2% in Q2 2026, selling an estimated $15.2K and leaving 23,271 shares worth $1.27M. The position accounts for 0.01% of the portfolio, ranked #1031.

Arizona State Retirement System first reported a position in CRSP in Q1 2020 and has held it in 26 quarters since. The position peaked at $2.65M in Q2 2021. 523 funds tracked by Wall St. Rank hold CRSP as of Q2 2026.

  • Arizona State Retirement System held 23,271 shares of CRISPR Therapeutics worth $1.27M as of Q2 2026.
  • Arizona State Retirement System sold 288 CRISPR Therapeutics shares in Q2 2026, an estimated $15.2K.
  • CRISPR Therapeutics made up 0.01% of Arizona State Retirement System's portfolio in Q2 2026, its #1031 holding.
  • Arizona State Retirement System first reported a position in CRISPR Therapeutics in Q1 2020 and has held it in 26 quarters since.
  • Arizona State Retirement System's CRISPR Therapeutics position peaked at $2.65M in Q2 2021.
  • 523 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q2 2026.

Based on Arizona State Retirement System's 13F filing for Q2 2026, filed 7 Aug 2026.